Skip to content

   Pharma Publications

Neuropsychopharmacology
  • No time to lose: the current state of research in rapid-acting psychotherapeutics
    Published on 2023-06-22
    3 years ago
  • Ketamine in neuropsychiatric disorders: an update
    Published on 2023-06-20
    3 years ago
  • Exploring the multiverse: the impact of researchers’ analytic decisions on relationships between depression and inflammatory markers
    Published on 2023-06-19
    3 years ago
  • Microglia depletion facilitates the display of maternal behavior and alters activation of the maternal brain network in nulliparous female rats
    Published on 2023-06-17
    3 years ago
  • Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
    Published on 2023-06-15
    3 years ago
  • The effect of ketamine on synaptic mistuning induced by impaired glutamate reuptake
    Published on 2023-06-10
    3 years ago
  • Publisher Correction to: Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques
    Published on 2023-06-07
    3 years ago
« Previous 1 … 133 134 135 136 137 … 143 Next »
Journal of Psychopharmacology
  • No evidence for the involvement of serotonin or the 5-HTTLPR genotype in intertemporal choice in a larger community sample
    Published on 2019-09-24
    7 years ago
  • The presence of a social stimulus reduces cocaine-seeking in a place preference conditioning paradigm
    Published on 2019-09-23
    7 years ago
  • The impacts of actual and perceived nicotine administration on insula functional connectivity with the anterior cingulate cortex and nucleus accumbens
    Published on 2019-09-23
    7 years ago
  • Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence
    Published on 2019-09-19
    7 years ago
  • Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial
    Published on 2019-09-18
    7 years ago
  • Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study
    Published on 2019-09-17
    7 years ago
  • Dopamine D2 receptor stimulation modulates the balance between ignoring and updating according to baseline working memory ability
    Published on 2019-09-17
    7 years ago
« Previous 1 … 133 134 135 136 137 … 154 Next »
European Neuropsychopharmacology
  • P.845The effect of antipsychotic therapy on the social functioning of patients with paranoid schizophrenia
    Published on 2020-11-25
    6 years ago
  • P.860Compassion fatigue, burnout and hopelessness of the health workers in COVID-19 pandemic emergency
    Published on 2020-11-25
    6 years ago
  • P.846Definitions of antipsychotic response based on clinician-rated instruments in patients with delusional disorder: a systematic review
    Published on 2020-11-25
    6 years ago
  • P.816Early onset of action for trazodone antidepressant activity: insight into potential molecular mechanism
    Published on 2020-11-25
    6 years ago
  • P.847AUT00206 improves speech in noise recognition in patients with schizophrenia
    Published on 2020-11-25
    6 years ago
  • P.840Psychosis associated with antibodies against the NMDA receptors: a systematic review
    Published on 2020-11-25
    6 years ago
  • P.848Functionality in patients with newly diagnosed schizophrenia treated with paliperidone palmitate 3-month formulation in real-world clinical practice study (TIME study)
    Published on 2020-11-25
    6 years ago
« Previous 1 … 133 134 135 136 137 … 170 Next »

   Pharma Pub